Remove 2014 Remove Competition Remove Doctors
article thumbnail

Biogen’s $900 million settlement signals scrutiny on speaker fees

Pharmaceutical Technology

Between 2009 and 2014, the time period of Biogen’s alleged misconduct, the standard of care for MS involved the use of Biogen’s immunomodulatory drugs such as Avonex (Interferon beta-1a), Tecfidera (dimethyl fumarate), and Tysabri (natalizumab). More recently, Biogen has been facing competition from dimethyl fumarate generics.

article thumbnail

Building CO2-neutral, defossilised supply chains for chemicals

European Pharmaceutical Review

16,17 However, care must be taken to ensure that chemicals from biomass are not produced in competition with food production and do not have a negative impact on the environment or natural habitats. Chem Commun 2014, 50, 9650‒9652. Hoffmann-La Roche Ltd based in Basel, Switzerland. Org Process Res Dev 2022, 26, 9, 2685–2693.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Liron Fendell

Cadensee

Until back in 2014, I met the team at Schneider Children's Medical Center of Israel. They were just at the phase when they were looking for someone to come up with a more business perspective to join the doctors and really start to commercialize the supplements that were just developed at Schneider's at the time.

Retail 52
article thumbnail

Medical Sales In Sterile Processing And Infection Prevention With Mark Copeland

Evolve Your Success

He also talks about partnering with small businesses and how they are leading the competition in this particular space. I find reps, doctors, and directors. The way these doctors make decisions and the way these things occur, for whatever reason, it fascinated me. I left them in 2014 to start our own thing. They got big.

article thumbnail

Driving Provider Engagement in Value-Based Care

Clarify Health

And frankly, if you’re paying a provider 57% of the 2014 CMS schedule, they’re not going to be terribly excited about you putting this bonus program in front of them when they’re concentrating on that. You are not trying to, as the payer, out-doctor your doctors. They’re competitive by nature.

article thumbnail

How Integrated Delivery Systems Are Transforming Healthcare

Healthcare Success

And that's sort of important to the narrative today, I think, because had I not had that sort of pit stop for 5 years, and where we were, you know, in our doctoral seminars, like inventing value, based care models and testing them and kind of just going back and forth with other students. And in Dartmouth's kind of interdisciplinary program.

article thumbnail

Will A.I. Replace the Medical Sales Workforce and Surgeons? With Edouard Saget

Evolve Your Success

Sometimes my competition will take that article and say, “I could plus or minus 10 millimeters.” The pathways, honestly, if I were to do it again, the first thing I would do is go find a doctor, any of them depending on what the fields are, and then ask for recommendations for who they work with our current sales reps. It was rough.